Bicycle Therapeutics (BCYC) Non-Current Debt (2020 - 2024)

Bicycle Therapeutics (BCYC) has 5 years of Non-Current Debt data on file, last reported at $8.5 million in Q2 2024.

• For the quarter ending Q2 2024, Non-Current Debt fell 72.13% year-over-year to $8.5 million; the trailing twelve-month figure through Jun 2024 stood at $8.5 million (down 72.13% YoY), and the FY2023 full-year result was $30.7 million, up 1.26% from the prior year.
• Non-Current Debt for Q2 2024 stood at $8.5 million, down from $30.8 million in the prior quarter.
• Across five years, Non-Current Debt topped out at $30.8 million in Q1 2024 and bottomed at $8.5 million in Q2 2024.
• The 5-year median for Non-Current Debt is $30.1 million (2022), against an average of $26.9 million.
• The widest annual swing landed in 2021, when Non-Current Debt soared 106.23%; it then sank 72.13% in 2024.
• A 5-year view of Non-Current Debt shows it stood at $14.5 million in 2020, then surged by 105.95% to $29.9 million in 2021, then grew by 1.48% to $30.3 million in 2022, then advanced by 1.26% to $30.7 million in 2023, then tumbled by 72.29% to $8.5 million in 2024.
• The last three Non-Current Debt figures came in at $8.5 million (Q2 2024), $30.8 million (Q1 2024), and $30.7 million (Q4 2023), per Business Quant data.

Peer Comparison